Operating cash flow increased 28.7%
Operating cash flow changed +28.7% from the comparable as-filed period.
$45.1B→$58.0B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MSFT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 27.4%
Free-cash-flow proxy changed -27.4% from the comparable as-filed period.
$25.7B→$18.6B2 prior comparisons
Net income increased 32.0%
Net income changed +32.0% from the comparable as-filed period.
$27.7B→$36.6B2 prior comparisons
Operating income increased 21.0%
Operating income changed +21.0% from the comparable as-filed period.
$38.0B→$45.9B2 prior comparisons
Capital expenditure increased 103.0%
Capital expenditure changed +103.0% from the comparable as-filed period.
$19.4B→$39.4B2 prior comparisons
Capex / revenue moved 1769 bp higher
Capex / revenue changed +1769 basis points from the comparable as-filed period.
24.97%→42.66%2 prior comparisons
Current long-term debt decreased 43.9%
Current long-term debt changed -43.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$7.8B→$4.4B3 prior comparisons
Stockholders' equity increased 29.6%
Stockholders' equity changed +29.6% from the comparable as-filed period.
$363.1B→$470.5B2 prior comparisons
Revenue increased 18.8%
Revenue changed +18.8% from the comparable as-filed period.
$77.7B→$92.3B2 prior comparisons
Working capital decreased 36.8%
Working capital changed -36.8% from the comparable as-filed period.
$54.1B→$34.2B3 prior comparisons
Cash & equivalents decreased 29.7%
Cash & equivalents changed -29.7% from the comparable as-filed period.
$28.8B→$20.3B3 prior comparisons
Operating cash flow increased 26.0%
Operating cash flow changed +26.0% from the comparable as-filed period.
$37.0B→$46.7B0 prior comparisons
Free-cash-flow proxy decreased 22.1%
Free-cash-flow proxy changed -22.1% from the comparable as-filed period.
$20.3B→$15.8B0 prior comparisons
Net debt decreased 42.0%
Net debt changed -42.0% from the comparable as-filed period.
$14.1B→$8.2B2 prior comparisons
Operating income increased 20.0%
Operating income changed +20.0% from the comparable as-filed period.
$32.0B→$38.4B0 prior comparisons
Capital expenditure increased 84.4%
Capital expenditure changed +84.4% from the comparable as-filed period.
$16.7B→$30.9B0 prior comparisons
Capex / revenue moved 1335 bp higher
Capex / revenue changed +1335 basis points from the comparable as-filed period.
23.90%→37.25%0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.